Lysozyme-Induced Nephropathy: A Diagnosis Not to Forget
- PMID: 36865968
- PMCID: PMC9974170
- DOI: 10.7759/cureus.34344
Lysozyme-Induced Nephropathy: A Diagnosis Not to Forget
Abstract
Kidney injury in hematologic malignancies can manifest in many ways. We present a case report of a 44-year-old female with de novo acute myeloid leukemia (AML) and acute kidney injury. Following the etiological investigation, lysozyme-induced nephropathy was believed to be the most probable cause of renal injury. Intensive cytoreduction and chemotherapy were started and the patient's cytopenias and kidney injury have improved. This case highlights the importance of recognizing lysozyme-induced nephropathy as a form of kidney injury in AML. Despite being frequently underrecognized, a precocious diagnosis may impact the patient's prognosis.
Keywords: acute kidney injury; case report; hematologic malignancies; lysozyme; lysozyme-induced nephropathy.
Copyright © 2023, Paulo et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Kidney involvement in leukemia and lymphoma. Luciano RL, Brewster UC. Adv Chronic Kidney Dis. 2014;21:27–35. - PubMed
-
- Progressive kidney failure in chronic myelomonocytic leukaemia: don't forget lysozyme damage. Hillen JM, Raemaekers JM, Steenbergen EJ, Wetzels JF, Verhave JC. https://pubmed.ncbi.nlm.nih.gov/30465656/ Neth J Med. 2018;76:407–410. - PubMed
Publication types
LinkOut - more resources
Full Text Sources